Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
The financing gives ReShape, formerly known as EnteroMedics, money to commercialize its weight loss devices, but the move caused investors to buck.
The company makes the XTRAC excimer laser and VTRAC lamp systems used for treating various skin conditions.
With Inari's commercial opportunities increasing, it has pulled in its biggest round to date to fuel a sales and marketing push.
The involvement of Abbott and other investors means Bigfoot has $55 million to take its insulin pump and pen through clinical development.
The test builds on Abionic’s work to develop an immunoassay platform that delivers results faster than the traditional laboratory-based process.
Polarean, a North Carolina-based devicemaker focused on the MRI market, said it plans to raise as much as $4.3 million in a public offering listing.
SafeHeal snapped up $7.4 million in series A funding that it will use to continue its efforts toward the commercial launch of its Colovac device.
ArcherDX will use the money to grow its commercial operations while building out the companion diagnostic program that landed it a deal with Celgene.
The financing equips Oxford Nanopore to scale up its operation as it moves deeper into territory colonized by Illumina and Pacific Biosciences.
Devicemaker Orthofix is acquiring Spinal Kinetics, which manufactures artificial cervical and lumbar discs, in a deal that could be worth up to $105 million.…